|
| Status |
Public on Jan 01, 2016 |
| Title |
SUP-HD1_1B |
| Sample type |
RNA |
| |
|
| Source name |
SUP-HD1_24hrs_control
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: SUP-HD1
cell type: Hodgkin Lymphoma
treatment: CTRL
time exposure: 24hrs
|
| Biomaterial provider |
DSMZ
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
| |
|
| Hybridization protocol |
Standard Illumina hybridization protocol
|
| Scan protocol |
Standard Illumina scanning protocol
|
| Description |
Replicate2
|
| Data processing |
The data were processed and normalised using quantile normalisation with BeadStudio software
|
| |
|
| Submission date |
Jun 27, 2014 |
| Last update date |
Jan 01, 2016 |
| Contact name |
Giuliano Giuseppe Stirparo |
| E-mail(s) |
[email protected]
|
| Organization name |
Cerevance ltd
|
| Street address |
418 Cambridge Science Park Milton Rd
|
| City |
Cambridge |
| State/province |
Cambridgeshire |
| ZIP/Postal code |
CB4 0PZ |
| Country |
United Kingdom |
| |
|
| Platform ID |
GPL10558 |
| Series (1) |
| GSE58899 |
Gene expression profiling of L-540, SUP-HD1, KM-H2 and L-428 Hodgkin lymphoma cell lines after in vitro and in vivo treatment with the dual PI3K/ERK inhibitor AEZS-136 |
|
